{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:27:06Z","timestamp":1790972826182,"version":"4.1.0"},"reference-count":87,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.rdc.2012.08.012","type":"journal-article","created":{"date-parts":[[2012,9,13]],"date-time":"2012-09-13T02:46:14Z","timestamp":1347504374000},"page":"569-582","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Pathophysiology and Role of the Gastrointestinal System in Spondyloarthritides"],"prefix":"10.1016","volume":"38","author":[{"given":"Peggy","family":"Jacques","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesbet","family":"Van Praet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Carron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Van den Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Elewaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rdc.2012.08.012_bib1","first-page":"2273","article-title":"The evolution of spondylarthropathies in relation to gut histology. II. Histological aspects","volume":"22","author":"Mielants","year":"1995","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2012.08.012_bib2","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1136\/ard.2004.021774","article-title":"Radiological sacroiliitis, a hallmark of spondylitis, is linked with CARD15 gene polymorphisms in patients with Crohn's disease","volume":"63","author":"Peeters","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2012.08.012_bib3","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/art.1780210210","article-title":"Quantitative sacroiliac scintigraphy in patients with Crohn\u2019s disease","volume":"21","author":"Davis","year":"1978","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2012.08.012_bib4","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1136\/gut.28.4.394","article-title":"Histopathology of intestinal inflammation related to reactive arthritis","volume":"28","author":"Cuvelier","year":"1987","journal-title":"Gut"},{"key":"10.1016\/j.rdc.2012.08.012_bib5","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1111\/j.1572-0241.2000.02262.x","article-title":"Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study","volume":"95","author":"Felder","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rdc.2012.08.012_bib6","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1572-0241.2002.05608.x","article-title":"Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease","volume":"97","author":"Mahadevan","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rdc.2012.08.012_bib7","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/00054725-200407000-00005","article-title":"The spectrum of gastrointestinal toxicity and effect on disease activity of selective cyclooxygenase-2 inhibitors in patients with inflammatory bowel disease","volume":"10","author":"Matuk","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.rdc.2012.08.012_bib8","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S1542-3565(05)00980-8","article-title":"Prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease","volume":"4","author":"Takeuchi","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.rdc.2012.08.012_bib9","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1046\/j.1365-2036.2003.01596.x","article-title":"An open-label trial of the selective cyclo-oxygenase-2 inhibitor, rofecoxib, in inflammatory bowel disease-associated peripheral arthritis and arthralgia","volume":"17","author":"Reinisch","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rdc.2012.08.012_bib10","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1365-2036.2004.01907.x","article-title":"Rofecoxib and early relapse of inflammatory bowel disease: an open-label trial","volume":"19","author":"Biancone","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rdc.2012.08.012_bib11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cgh.2005.12.002","article-title":"Safety of celecoxib in patients with ulcerative colitis in remission: a randomized, placebo-controlled, pilot study","volume":"4","author":"Sandborn","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.rdc.2012.08.012_bib12","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1572-0241.2006.00384.x","article-title":"The gastrointestinal safety and effect on disease activity of etoricoxib, a selective cox-2 inhibitor in inflammatory bowel diseases","volume":"101","author":"El Miedany","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rdc.2012.08.012_bib13","series-title":"Ankylosing spondylitis and reactive arthritis : pathogenic aspects and therapeutic consequences","author":"Mielants","year":"1988"},{"key":"10.1016\/j.rdc.2012.08.012_bib14","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nrrheum.2012.41","article-title":"Genetics of spondyloarthritis-beyond the MHC","volume":"8","author":"Reveille","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.rdc.2012.08.012_bib15","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1002\/art.22812","article-title":"A\u00a0common genetic background for inflammatory bowel disease and ankylosing spondylitis: a genealogic study in Iceland","volume":"56","author":"Thjodleifsson","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"9248","key":"10.1016\/j.rdc.2012.08.012_bib16","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/S0140-6736(00)03488-7","article-title":"Serological diagnosis of inflammatory bowel disease","volume":"356","author":"Rutgeerts","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.rdc.2012.08.012_bib17","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/ard.62.5.455","article-title":"Anti-saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy","volume":"62","author":"Hoffman","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2012.08.012_bib18","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.3899\/jrheum.100269","article-title":"pANCA, ASCA, and OmpC antibodies in patients with ankylosing spondylitis without inflammatory bowel disease","volume":"37","author":"de Vries","year":"2010","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2012.08.012_bib19","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/ncpgasthep0528","article-title":"Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis","volume":"3","author":"Sartor","year":"2006","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"10.1016\/j.rdc.2012.08.012_bib20","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/gut.2003.025403","article-title":"Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease","volume":"53","author":"Ott","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.rdc.2012.08.012_bib21","doi-asserted-by":"crossref","first-page":"13780","DOI":"10.1073\/pnas.0706625104","article-title":"Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases","volume":"104","author":"Frank","year":"2007","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.rdc.2012.08.012_bib22","doi-asserted-by":"crossref","first-page":"295","DOI":"10.5009\/gnl.2010.4.3.295","article-title":"The role of bacteria in the pathogenesis of inflammatory bowel disease","volume":"4","author":"Friswell","year":"2010","journal-title":"Gut Liver"},{"key":"10.1016\/j.rdc.2012.08.012_bib23","first-page":"954051","article-title":"The bowel microbiota and inflammatory bowel diseases","volume":"2010","author":"Tannock","year":"2010","journal-title":"Int J Inflam"},{"key":"10.1016\/j.rdc.2012.08.012_bib24","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1002\/ibd.21319","article-title":"Dysbiosis of fecal microbiota in Crohn's disease patients as revealed by a custom phylogenetic microarray","volume":"16","author":"Kang","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.rdc.2012.08.012_bib25","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1046\/j.1365-2362.2000.00696.x","article-title":"Differential expression of human alpha- and beta-defensins mRNA in gastrointestinal epithelia","volume":"30","author":"Frye","year":"2000","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.rdc.2012.08.012_bib26","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1016\/j.febslet.2006.08.083","article-title":"Paneth cell antimicrobial peptides: topographical distribution and quantification in human gastrointestinal tissues","volume":"580","author":"Wehkamp","year":"2006","journal-title":"FEBS Lett"},{"key":"10.1016\/j.rdc.2012.08.012_bib27","doi-asserted-by":"crossref","first-page":"18129","DOI":"10.1073\/pnas.0505256102","article-title":"Reduced Paneth cell alpha-defensins in ileal Crohn's disease","volume":"102","author":"Wehkamp","year":"2005","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.rdc.2012.08.012_bib28","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1093\/rheumatology\/keq239","article-title":"Over-expression of Paneth cell-derived anti-microbial peptides in the gut of patients with ankylosing spondylitis and subclinical intestinal inflammation","volume":"49","author":"Ciccia","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.rdc.2012.08.012_bib29","first-page":"13","article-title":"Development and maintenance of the gut-associated lymphoid tissue (GALT): the roles of enteric bacteria and viruses","volume":"6","author":"Cebra","year":"1998","journal-title":"Dev Immunol"},{"key":"10.1016\/j.rdc.2012.08.012_bib30","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1159\/000231071","article-title":"Factors affecting the lymphoid cells in the small intestinal epithelium of the mouse","volume":"45","author":"Glaister","year":"1973","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"10.1016\/j.rdc.2012.08.012_bib31","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1084\/jem.180.6.2359","article-title":"The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats","volume":"180","author":"Taurog","year":"1994","journal-title":"J\u00a0Exp Med"},{"issue":"11","key":"10.1016\/j.rdc.2012.08.012_bib32","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1002\/art.30558","article-title":"Hypothesis: time for a gut check: HLA B27 predisposes to ankylosing spondylitis by altering the microbiome","volume":"63","author":"Rosenbaum","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2012.08.012_bib33","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0167-5699(90)90051-A","article-title":"Guilt by association: HLA-B27 and ankylosing spondylitis","volume":"11","author":"Benjamin","year":"1990","journal-title":"Immunol Today"},{"key":"10.1016\/j.rdc.2012.08.012_bib34","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1002\/art.10605","article-title":"Cell-surface expression and immune receptor recognition of HLA-B27 homodimers","volume":"46","author":"Kollnberger","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2012.08.012_bib35","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0889-857X(21)00707-9","article-title":"Do bacterial antigens cause reactive arthritis?","volume":"18","author":"Granfors","year":"1992","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.rdc.2012.08.012_bib36","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1084\/jem.181.1.137","article-title":"Dual binding capacity of mucosal immunoblasts to mucosal and synovial endothelium in humans: dissection of the molecular mechanisms","volume":"181","author":"Salmi","year":"1995","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.rdc.2012.08.012_bib37","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/ard.2003.018382","article-title":"Colon mucosa of patients both with spondyloarthritis and Crohn's disease is enriched with macrophages expressing the scavenger receptor CD163","volume":"64","author":"Demetter","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2012.08.012_bib38","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/path.1044","article-title":"Macrophages expressing the scavenger receptor CD163: a link between immune alterations of the gut and synovial inflammation in spondyloarthropathy","volume":"196","author":"Baeten","year":"2002","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.rdc.2012.08.012_bib39","doi-asserted-by":"crossref","first-page":"R359","DOI":"10.1186\/ar1501","article-title":"Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathy","volume":"7","author":"Baeten","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.rdc.2012.08.012_bib40","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1074-7613(00)80038-2","article-title":"Impaired on\/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies","volume":"10","author":"Kontoyiannis","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.rdc.2012.08.012_bib41","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1084\/jem.20070906","article-title":"Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseases","volume":"205","author":"Armaka","year":"2008","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.rdc.2012.08.012_bib42","doi-asserted-by":"crossref","first-page":"5396","DOI":"10.1073\/pnas.1007811108","article-title":"Intestinal epithelial cells as producers but not targets of chronic TNF suffice to cause murine Crohn-like pathology","volume":"108","author":"Roulis","year":"2011","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.rdc.2012.08.012_bib43","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1136\/ard.59.12.945","article-title":"Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy, and osteoarthritis: influence of disease duration and activity","volume":"59","author":"Baeten","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2012.08.012_bib44","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/ard.60.8.750","article-title":"Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFalpha","volume":"60","author":"Baeten","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2012.08.012_bib45","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/ard.59.4.263","article-title":"Differential Th1\/Th2 cytokine patterns in chronic arthritis: interferon gamma is highly expressed in synovium of rheumatoid arthritis compared with seronegative spondyloarthropathies","volume":"59","author":"Canete","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2012.08.012_bib46","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1600-065X.2006.00482.x","article-title":"Generation of gut-homing T cells and their localization to the small intestinal mucosa","volume":"215","author":"Johansson-Lindbom","year":"2007","journal-title":"Immunol Rev"},{"key":"10.1016\/j.rdc.2012.08.012_bib47","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/372190a0","article-title":"Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the alpha E beta 7 integrin","volume":"372","author":"Cepek","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.rdc.2012.08.012_bib48","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.cgh.2008.06.007","article-title":"Treatment of active Crohn's disease with MLN0002, a humanized antibody to the alpha4beta7 integrin","volume":"6","author":"Feagan","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.rdc.2012.08.012_bib49","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa042982","article-title":"Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin","volume":"352","author":"Feagan","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rdc.2012.08.012_bib50","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.4049\/jimmunol.158.5.2099","article-title":"Monoclonal antibodies specific for beta 7 integrin and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) reduce inflammation in the colon of scid mice reconstituted with CD45RBhigh CD4+ T cells","volume":"158","author":"Picarella","year":"1997","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.rdc.2012.08.012_bib51","first-page":"288","article-title":"Altered expression of alpha E beta 7 integrin on intra-epithelial and lamina propria lymphocytes in patients with Crohn's disease","volume":"61","author":"Elewaut","year":"1998","journal-title":"Acta Gastroenterol Belg"},{"key":"10.1016\/j.rdc.2012.08.012_bib52","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.4049\/jimmunol.166.7.4650","article-title":"Human leukocyte subpopulations from inflamed gut bind to joint vasculature using distinct sets of adhesion molecules","volume":"166","author":"Salmi","year":"2001","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.rdc.2012.08.012_bib53","first-page":"1932","article-title":"Enrichment of T cells carrying beta7 integrins in inflamed synovial tissue from patients with early spondyloarthropathy, compared to rheumatoid arthritis","volume":"25","author":"Elewaut","year":"1998","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2012.08.012_bib54","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1002\/eji.1830250602","article-title":"Transforming growth factor-beta 1-induced expression of the mucosa-related integrin alpha E on lymphocytes is not associated with mucosa-specific homing","volume":"25","author":"Austrup","year":"1995","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.rdc.2012.08.012_bib55","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1365-3083.1995.tb03607.x","article-title":"Expression of the human mucosal lymphocyte antigen, HML-1, by T cells activated with mitogen or specific antigen in\u00a0vitro","volume":"41","author":"Brew","year":"1995","journal-title":"Scand J Immunol"},{"issue":"1","key":"10.1016\/j.rdc.2012.08.012_bib56","article-title":"Natalizumab for induction of remission in Crohn's disease","author":"MacDonald","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.rdc.2012.08.012_bib57","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1002\/ibd.21896","article-title":"Vedolizumab for the treatment of active ulcerative colitis: a randomized controlled phase 2 dose-ranging study","volume":"18","author":"Parikh","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.rdc.2012.08.012_bib58","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00439-007-0397-0","article-title":"Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis","volume":"122","author":"Capon","year":"2007","journal-title":"Hum Genet"},{"key":"10.1016\/j.rdc.2012.08.012_bib59","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1126\/science.1135245","article-title":"A\u00a0genome-wide association study identifies IL23R as an inflammatory bowel disease gene","volume":"314","author":"Duerr","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.rdc.2012.08.012_bib60","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1002\/art.24763","article-title":"HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats","volume":"60","author":"DeLay","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2012.08.012_bib61","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/art.24389","article-title":"Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis","volume":"60","author":"Ciccia","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.rdc.2012.08.012_bib62","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1136\/ard.2009.107649","article-title":"Systemic levels of IL-23 are strongly associated with disease activity in rheumatoid arthritis but not spondyloarthritis","volume":"69","author":"Melis","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2012.08.012_bib63","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nm.2817","article-title":"IL-23 induces spondyloarthropathy by acting on ROR-\u03b3t+ CD3+CD4\u2212CD8\u2212 entheseal resident T cells","volume":"18","author":"Sherlock","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.rdc.2012.08.012_bib64","doi-asserted-by":"crossref","first-page":"R95","DOI":"10.1186\/ar3370","article-title":"Analysis of IL-17+ cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the\u00a0Th17-mediated adaptive immune response","volume":"13","author":"Appel","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.rdc.2012.08.012_bib65","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nature07537","article-title":"A\u00a0human natural killer cell subset provides an innate source of IL-22 for mucosal immunity","volume":"457","author":"Cella","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.rdc.2012.08.012_bib66","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/156652409787314534","article-title":"Natural killer T cells and autoimmune disease","volume":"9","author":"Wu","year":"2009","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.rdc.2012.08.012_bib67","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/ni.1818","article-title":"Regulatory T cells exert checks and balances on self tolerance and autoimmunity","volume":"11","author":"Wing","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.rdc.2012.08.012_bib68","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/ni1180","article-title":"Mechanisms of suppression by suppressor T cells","volume":"6","author":"von Boehmer","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.rdc.2012.08.012_bib69","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1053\/j.gastro.2005.03.043","article-title":"Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease","volume":"128","author":"Maul","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rdc.2012.08.012_bib70","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.clim.2007.08.003","article-title":"Characterization of FOXP3+CD4+ regulatory T cells in Crohn's disease","volume":"125","author":"Saruta","year":"2007","journal-title":"Clin Immunol"},{"key":"10.1016\/j.rdc.2012.08.012_bib71","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ibd.21308","article-title":"Therapy with anti-TNFalpha antibody enhances number and function of Foxp3(+) regulatory T cells in inflammatory bowel diseases","volume":"17","author":"Boschetti","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.rdc.2012.08.012_bib72","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/ibd.21271","article-title":"Peripheral regulatory T cells and serum transforming growth factor-beta: relationship with clinical response to infliximab in Crohn's disease","volume":"16","author":"Di Sabatino","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.rdc.2012.08.012_bib73","doi-asserted-by":"crossref","first-page":"R335","DOI":"10.1186\/ar1192","article-title":"CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease","volume":"6","author":"Cao","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.rdc.2012.08.012_bib74","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.3899\/jrheum.110377","article-title":"Synovial and peripheral blood CD4+FoxP3+ T cells in spondyloarthritis","volume":"38","author":"Appel","year":"2011","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2012.08.012_bib75","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1002\/art.27699","article-title":"Expansion of intestinal CD4+CD25(high) Treg cells in patients with ankylosing spondylitis: a putative role for interleukin-10 in preventing intestinal Th17 response","volume":"62","author":"Ciccia","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2012.08.012_bib76","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/art.27324","article-title":"Invariant natural killer T cells are natural regulators of murine spondylarthritis","volume":"62","author":"Jacques","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2012.08.012_bib77","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11926-011-0198-2","article-title":"Mucosal inflammation in spondylarthritides: past, present, and future","volume":"13","author":"Van Praet","year":"2011","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.rdc.2012.08.012_bib78","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/rheumatology\/kep146","article-title":"Treatment of ankylosing spondylitis and extra-articular manifestations in everyday rheumatology practice","volume":"48","author":"Elewaut","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.rdc.2012.08.012_bib79","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/ard.2011.151027","article-title":"2010 update of the ASAS\/EULAR recommendations for the management of ankylosing spondylitis","volume":"70","author":"Braun","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2012.08.012_bib80","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1136\/gutjnl-2011-300904","article-title":"New therapies for inflammatory bowel disease: from the bench to the bedside","volume":"61","author":"Danese","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.rdc.2012.08.012_bib81","unstructured":"Certolizumab pegol in subjects with active axial spondyloarthritis. 2012. Available at: ClinicalTrials.gov[online]."},{"issue":"Suppl 3","key":"10.1016\/j.rdc.2012.08.012_bib82","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/annrheumdis-2012-eular.1849","article-title":"Tocilizumab (TCZ) is not effective for the treatment of ankylosing spondylitis (AS): results of a phase 2, international, multicentre, randomised, double-blind, placebo-controlled trial","volume":"71","author":"Sieper","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2012.08.012_bib83","unstructured":"Ustekinumab for the Treatment of Patients with Active Ankylosing Spondylitis (TOPAS). 2012. Available at: ClinicalTrials.gov[online]."},{"key":"10.1016\/j.rdc.2012.08.012_bib84","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1136\/ard.2010.145946","article-title":"Treatment of active ankylosing spondylitis with abatacept: an open-label, 24-week pilot study","volume":"70","author":"Song","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2012.08.012_bib85","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jbspin.2011.02.018","article-title":"Lack of efficacy of abatacept in axial spondylarthropathies refractory to tumor-necrosis-factor inhibition","volume":"79","author":"Lekpa","year":"2012","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.rdc.2012.08.012_bib86","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/art.27383","article-title":"Different response to rituximab in tumor necrosis factor blocker-naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: a twenty-four-week clinical trial","volume":"62","author":"Song","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2012.08.012_bib87","first-page":"2486D","article-title":"Interleukin-17A blockade with secukinumab reduces spinal inflammation in patients with ankylosing spondylitis as early as week 6, as detected by magnetic resonance imaging","volume":"63","author":"Baraliakos","year":"2011","journal-title":"Arthritis Rheum"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X12000713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X12000713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:11:23Z","timestamp":1760181083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X12000713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":87,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0889857X12000713"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2012.08.012","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathophysiology and Role of the Gastrointestinal System in Spondyloarthritides","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2012.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}